yes and recent comments comming out of us officialdome point to conceding that tamiflu and permiravir have limited lives --- now what does that leave -- it leaves the whole field to rlenza and lani - possibly by the end of nth hemisphere flu season. This probably is the logic and justification for gsk ramping production up further- you can gaurantee most restocking of stockpiles wont be with tamiflu. What a time in the history of anti virals to be negotiating a license deal for lani - my guess is that those large pharmas are on there knees - and that this could be a lot bigger deal for biota than many think - but not all on this site thats for sure. If you are talking about dissapointment - then i'll tell you - i'll be dissapointed with anything less than $10- $20/PER SHARE WITHIN TWELVE MTHS.Dont forget that once you get to $10 - you only have to double to get to twenty.good news is contagious.
- Forums
- ASX - By Stock
- BTA
- resistance to tamiflu and permarivir increases
resistance to tamiflu and permarivir increases, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online